Human mutations in LRP5 and SOST (sclerostin) alter WNT signaling and cause osteoporosis-pseudoglioma syndrome (OPPG) and van Buchem disease. The gene discussed is SOST; the disease is osteoporosis-pseudoglioma syndrome.